Abstract
This is a commentary about the evolution of safety reporting, the new FDA Draft Guidance on Safety Reporting and possible paths forward.
Keywords
Get full access to this article
View all access options for this article.
You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026
Select search scope: search across all journals or within the current journal
This is a commentary about the evolution of safety reporting, the new FDA Draft Guidance on Safety Reporting and possible paths forward.
View all access options for this article.